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Abstract
 
The generalized Shwartzman reaction in mice which had been primed and challenged with li-
popolysaccharide (LPS) depends on interleukin (IL)-12–induced interferon (IFN)-
 
g
 
 produc-
tion at the priming stage. We examined the involvement in the priming mechanism of the
 
unique population of V
 
a
 
14 natural killer T (NKT) cells because they promptly produce IFN-
 
g
 
after IL-12 stimulation. We report here that LPS- or IL-12–primed NKT cell genetically defi-
cient mice were found to be resistant to LPS-elicited mortality. This outcome can be attrib-
uted to the reduction of IFN-
 
g
 
 production, because injection of recombinant mouse IFN-
 
g
 
,
but not injection of IL-12, effectively primed the NKT cell–deficient mice. However, priming
with high doses of LPS caused mortality of severe combined immunodeficiency, NKT cell–
deficient, and CD1-deficient mice, indicating a major contribution of NKT cells to the
Shwartzman reaction elicited by low doses of LPS, whereas at higher doses of LPS NK cells
play a prominent role. These results suggest that the numerically small NKT cell population of
normal mice apparently plays a mandatory role in the priming stage of the generalized
Shwartzman reaction.
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g
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Introduction
 
The generalized Shwartzman reaction is a lethal shock syn-
drome of mice after two consecutive injections of LPS. IL-
12, IFN-
 
g
 
, and TNF-
 
a
 
 are known to be involved in the
pathogenesis (1), but IL-12 is pivotal in the priming phase
because it induces IFN-
 
g
 
 production (2, 3), which is cru-
cial for its ability to induce large amounts of TNF-
 
a
 
, IL-1,
and possibly other inflammatory cytokines. In any event,
IFN-
 
g
 
 production in the sensitization phase is essential for
the development of postchallenge mortality, because nei-
ther TNF-
 
a
 
 or IL-1 alone, nor a combination of both of
these cytokines, causes mortality (2).
NKT cells are a unique population of T lymphocytes
that express the NK1.1 molecule (4). They use an invariant
TCR 
 
a
 
 chain encoded by the V
 
a
 
14 and J
 
a
 
281 gene seg-
ments and are usually CD4
 
2
 
CD8
 
2
 
, although NKT cells re-
siding in the liver coexpress CD4 (5). Stimulation of NKT
cells by cross-linking the NK1.1 molecules (6), or incuba-
tion with either IL-12 (7) or the synthetic ligand 
 
a
 
-galacto-
sylceramide (8), promptly induces IFN-
 
g
 
 production.
 
We considered that the V
 
a
 
14 subset of NKT cells could
be involved in the generalized Shwartzman reaction on the
following grounds: (a) IL-12 exerts potent activation of
NKT cells and promotes very early IFN-
 
g
 
 production (6,
7); (b) inoculation of LPS activates NKT cells in the liver
through IL-12 production by Kupffer cells (9); and (c)
functional impairment or depletion of NKT cells by Abs to
cell surface markers (10, 11), or by genetic knockout of ei-
 
ther 
 
b
 
2
 
-microglobulin (11) or CD7 (12) molecules, resulted
in resistance against the generalized Shwartzman reaction.
However, the impairment of NKT cells in these studies also
affected other lymphoid populations or did not separate the
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LPS priming and elicitation phases. Furthermore, distinct
roles of NK and NKT cells were attributed in the LPS-
induced liver injury and mortality, respectively (13).
Therefore, it seemed desirable to focus further on the
identification of the cellular target, using mice with highly
selective depletion of the V
 
a
 
14 NKT cell subset in the thy-
mus, spleen, lymph nodes, liver, and bone marrow (14).
 
Materials and Methods
 
Mice.
 
C57BL/6, BALB/c, and C.B.-17 SCID mice were
purchased from OLAC Ltd. Generation of J
 
a
 
281-deficient mice
has been described previously (14). Mice which lack the J
 
a
 
281
gene segment are devoid of V
 
a
 
14
 
1
 
 NKT cells while having the
other lymphoid cell lineages intact (14). Homogeneous popula-
tions were established by backcrossing heterozygous mice to
C57BL/6 or BALB/c mice for more than five generations. The
resultant heterozygous mice were bred to obtain homozygotes
(14). CD1-deficient mice were purchased from The Jackson Lab-
oratory and backcrossed to C57BL/6 mice for five generations.
Mice were fed and kept under specific pathogen-free conditions
and used at 8–12 wk of age. In each experiment, age- and sex-
matched mice were used.
 
Induction of the Shwartzman Reaction. 
 
Mice were injected in-
travenously (11) with 40 
 
m
 
g 
 
Escherichia coli
 
–derived, phenol-
extracted LPS (Sigma-Aldrich), or intraperitoneally with 0.5 
 
m
 
g
recombinant murine IL-12 (specific activity 0.7–2.1 
 
3
 
 10
 
7
 
 U/mg;
BD PharMingen) or IFN-
 
g
 
 (specific activity 0.3–1 
 
3 
 
10
 
8
 
 U/mg;
BD PharMingen). Endotoxin levels of recombinant cytokines
were 
 
,
 
0.1 ng/
 
m
 
g protein. 24 h later, mice were challenged by
intravenous injection of 400 
 
m
 
g phenol-extracted LPS (11).
 
In the experiments reported in Fig. 3, mice were injected in-
travenously with different doses of two preparations of phenol-
extracted LPS, one of which was purified by ion-exchange chro-
matography (both preparations from Sigma-Aldrich), and were
challenged by intravenous injection of 400 
 
m
 
g phenol-extracted
LPS. The occurrence of generalized Shwartzman reaction was
evaluated by mortality.
 
Assay for Serum Cytokine Levels.
 
Serum levels of IL-12 and
IFN-
 
g
 
 were measured 20 h after priming with LPS or IL-12 (11).
TNF-
 
a
 
 serum levels were measured 1 h after challenge with LPS
(11). Cytokine levels were assessed by sandwich ELISA using
commercially available (BD PharMingen) pairs of mAbs and re-
combinant cytokines for setting standard curves.
 
Histological Analysis.
 
Mice were killed by cervical dislocation
8–12 h after challenge with LPS. The livers and kidneys were re-
moved immediately, fixed with 10% formalin for 12 h, and em-
bedded in paraffin. Several tissue sections were deparaffinized and
stained with hematoxylin and eosin.
 
Preparation of Liver Mononuclear Cells and Cell Sorting.
 
Liver
mononuclear cells were prepared as described (15). In brief, livers
were minced, passed through a mesh, and suspended in complete
RPMI 1640 (GIBCO BRL). After washing, the cells were resus-
pended in 30% Percoll containing 100 U/ml heparin and centri-
fuged at 2,000 rpm for 20 min at room temperature. The cell pel-
let was washed once in medium and then resuspended in cold
distilled water for 20 s to lyse red blood cells by osmotic shock.
After lysis, the cell suspension was diluted with NaCl solution to
readjust the osmotic pressure and was then washed with RPMI
1640 supplemented with 10% heat-inactivated FCS. NK1.1
 
1
 
 and
NK1.1
 
2
 
 cells were sorted by incubating liver mononuclear cells
with anti-NK1.1 (PK 136, mouse IgG2a; BD PharMingen) and
anti–mouse Ig-coated immunomagnetic beads (Advanced Mag-
 
Table I.
 
Induction of the Generalized Shwartzman Reaction in Normal and NKT-deficient Mice
 
Strain Priming Challenge
Deaths/
tested Mortality IL-12 IFN-
 
g
 
TNF-
 
a
 
n % ng/ml ng/ml ng/ml
 
C57BL/6
 
2
 
LPS 0/15 0
LPS
 
2
 
0/15 0
LPS LPS 13/15 93 1.2 
 
6 
 
4 7.8 
 
6 
 
1.4 80 
 
6 
 
10
C57BL/6 NKT
 
2
 
/
 
2
 
2
 
LPS 0/15 0
LPS
 
2
 
0/15 0
LPS LPS 1/15 7
 
*
 
1.3 
 
6 
 
0.2
 
0.2 
 
6 
 
0.05
 
‡
 
0.35 
 
6 
 
0.09
 
‡
 
BALB/c
 
2
 
LPS 0/15 0
LPS
 
2
 
0/15 0
LPS LPS 15/15 100 0.9 
 
6 
 
0.2 5.4 
 
6 
 
0.9 68 
 
6 
 
5
BALB/c NKT
 
2
 
/
 
2
 
2
 
LPS 0/15 0
LPS
 
2
 
0/15 0
LPS LPS 0/15 0
 
*
 
0.8 
 
6 
 
0.1
 
0.18 
 
6 
 
0.05
 
‡
 
0.25 
 
6 
 
0.06
 
‡
 
*
 
P
 
 
 
,
 
 0.00001 by the 
 
x
 
2
 
 test compared with normal C57BL/6 and BALB/c mice.
 
‡
 
Statistically significant compared with normal C57BL/6 and BALB/c mice (
 
P
 
 
 
,
 
 0.0001 by Student’s 
 
t
 
 test). 
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netics), as described previously (16). Purification of cell subsets
was routinely 
 
.
 
90% as determined by FACS
 
®
 
 analysis, and cell
viability was also 
 
.
 
90% as determined by trypan blue exclusion.
 
Intracellular Staining for IFN-
 
g
 
.
 
Intracellular staining was used
to determine IFN-
 
g
 
 production at the single cell level. NK1.1
 
1
 
and NK1.1
 
2
 
 cells were cultured for 5 h with Brefeldin A (Sigma-
Aldrich) to accumulate intracellularly new synthesized protein.
Cells were harvested and fixed with 4% (wt/vol) paraformalde-
hyde in PBS for 10 min at room temperature. Fixed cells were
suspended and washed twice with permeabilization buffer con-
taining 0.1% saponin (Sigma-Aldrich), 1% heat-inactivated FCS,
and 0.1% NaN
 
3 in PBS. The permeabilized cells were then incu-
bated in the presence of saponin with PE-conjugated anti–mouse
IFN-g mAb (XMG1.2, rat IgG1; BD PharMingen) or a PE-con-
jugated isotype control mAb (R3-34, rat IgG1; BD PharMingen)
for 30 min at room temperature. After being washed at room
temperature, the cells were analyzed with a FACScan™ flow cy-
tometer (Becton Dickinson). Viable lymphocytes were gated by
forward and side scatter and analysis was performed on 10,000 ac-
quired events for each sample.
Figure 1. Focal necrosis/apop-
tosis and mononuclear cell in-
filtrate in the liver and kidney of
untreated C57BL/6 mice (A), or
C57BL/6 (B) and NKT-defi-
cient C57BL/6 (C) mice in-
jected and challenged with LPS
(original magnification: 10 3
40). Asterisks indicate areas of
necrosis/apoptosis and arrows
indicate mononuclear cells infil-
tration.1648 NKT-deficient Mice Are Resistant to Shwartzman Reaction
To identify the phenotype of the IFN-g–producing cells, sur-
face marker analysis was performed by staining the cells with
FITC-conjugated anti–TCR-a/b (H57-597, hamster IgG; BD
PharMingen) before paraformaldehyde fixation.
Statistics. The x2 and the Student’s t tests were used to com-
pare significance of differences between groups.
Results and Discussion
The results obtained after priming and challenge with
LPS showed that both C57BL/6 and BALB/c mice had
very high 72-h mortality rates of 97% (13/15 mice) and
100% (15/15 mice), respectively, and very high serum lev-
els of IL-12, IFN-g, and TNF-a (Table I). However, a
strikingly high survival of 93% (14/15 mice) NKT-deficient
C57BL/6 mice and 100% (15/15) NKT-deficient BALB/c
mice was observed (Table I). Moreover, NKT-deficient
mice had low serum levels of IFN-g and TNF-a, whereas
serum IL-12 levels were comparable to control mice.
The histological analysis (Fig. 1) showed areas of focal
necrosis/apoptosis and mononuclear cell infiltrates in livers
and kidneys of control mice and very poor focal necrosis/
apoptosis and mononuclear cell infiltrates in the livers and
kidneys of NKT-deficient mice, thus corroborating the ob-
served mortality rates. Altogether, these results clearly dem-
onstrated that the lack of NKT cells protects mice from the
generalized Shwartzman reaction accompanied by reduced
levels of IFN-g and TNF-a.
The finding of reduced IFN-g, but normal IL-12 levels
in sera from NKT-deficient mice (Table I) suggested that
defective IFN-g production was responsible for protection
from lethal shock and that NKT cells were the main source
of LPS-induced IFN-g production.
We directly analyzed this finding by intracellular staining
of IFN-g produced by NK1.11 and NK1.12 cells sorted
from the livers of IL-12–primed NKT and control
C57LB/6 mice. The cell sorting analysis showed that in
normal C57BL/6 mice, IL-12 treatment increased from 0.3
to 42% the numbers of IFN-g1 cells (Fig. 2 B) at 6 h,
and combined cytoplasmic and surface analysis further
showed that NK1.11 cells were also ab1, whereas low
numbers of IFN-g–producing cells were detected within
the NK1.11ab2 population. However, as shown in Fig. 2,
Figure 2. IFN-g production by liver mononuclear cells
after priming with IL-12. NK1.11 and NK1.12 cells were
sorted from the livers of C57BL/6 (A and B) and NKT-
deficient (C and D) mice that had been primed 6 or 24 h
previously with IL-12, or left untreated (Nil). The cells
were surface stained with FITC-anti–TCR-a/b mAb and
intracellularly stained with PE-anti–IFN-g mAb, and ana-
lyzed by FACScan™. The analysis gate was set on small
lymphocytes by forward and side scattering. The figure
shows representative results from three different experi-
ments, each carried out with five mice per group.1649 Dieli et al. Brief Definitive Report
A and B, treatment with IL-12 for 24 h induced IFN-g
staining of both NK1.11ab2 (NK cells; Fig. 2 B) and
NK1.12ab2 cells (Fig. 2 A), whereas poor IFN-g staining
was detected within the NK1.11ab1 population (NKT
cells; Fig. 2 B).
These data have been confirmed in NKT cell–deficient
mice (Fig. 2, C and D): IL-12 treatment for 6 h induced
IFN-g production by both NK1.12ab2 (Fig. 2 C) and
NK1.11ab1 (Fig. 2 D) cells, and the percentages of
IFN-g1 NK1.12ab2 (Fig. 2 C) and NK1.11ab1 (Fig. 2
D) cells increased after 24 h of treatment with IL-12.
Together, the above reported results suggest that at an
early time (6 h) after IL-12 injection, NKT cells are the
main source of IFN-g in the liver, whereas at a later time
after IL-12 injection (24 h), NK cells (17, 18) and other
cells (presumably dendritic cells, as described recently [19])
become the main IFN-g–producing cells.
Of note, the absolute number of liver NKT cells was not
modified 6 h after IL-12 treatment (1.2 6 0.3 3 106/liver
in IL-12 treated mice vs. 1 6 0.4 3 106/liver in control
mice), but was strongly reduced 24 h after IL-12 treatment
(0.22 6 0.08 3 106/liver), thus supporting the possibility
that IL-12 causes activation-induced cell death of liver
NKT cells, as demonstrated recently (20).
It was of further major importance to compare the prim-
ing effects of IL-12 and IFN-g inoculation on the mortality
of LPS-challenged NKT cell–defective mice. The results
after IL-12 priming showed only very low mortality (1/15;
7%) in NKT cell–deficient mice, but high mortality (13/
15; 86%) of control mice (Table II, top). Accordingly,
NKT cell–deficient mice had lower serum levels of TNF-a
than control mice. This result suggests that the Va14 NKT
cell population was the primary functional target for IL-12
because the mutant mice exclusively lack Va14 NKT cells
while the other lymphoid populations are intact. We at-
tribute the failure of IL-12 to prime for the Shwartzman
reaction in NKT cell–deficient mice to their intrinsic de-
fect to produce IFN-g.
We further tested this hypothesis by priming the NKT
cell–deficient mice with IFN-g. As expected, the postchal-
lenge mortality was found to be high in both NKT cell–
deficient (10/15; 67%) and control (12/15; 80%) mice (Ta-
ble II, bottom). Both strains also had comparably elevated
serum levels of TNF-a.
Previous studies have reported a role for NK cells in the
response to LPS and Shwartzman reaction (10). Impor-
tantly, Caligiuri and coworkers (21) have clearly demon-
strated that the Shwartzman reaction can be elicited in
SCID mice, which have no NKT cells. To address the pos-
sible role of NK and NKT cells, we analyzed the Shwartz-
man reaction elicited by injection of different doses and
preparation of LPS in SCID, NKT-deficient, and CD1-defi-
cient and control mice.
The results obtained (Fig. 3 A) showed that normal
C57BL/6 mice had very high mortality rates of 90% (9/10
mice) upon priming with 50 mg LPS, whereas all SCID,
NKT-, and CD1-deficient mice survived this priming
dose. However, priming with 200 mg LPS caused 60–70%
mortality in SCID, NKT-deficient, and CD1-deficient
mice, and all the mutant mice succumbed after priming
with 500 mg LPS.
Similar results have been obtained using a different LPS
preparation purified by ion-exchange chromatography
(Fig. 3 B). In this experiment, 90% (9/10 mice) of normal
C57BL/6 mice succumbed upon priming with 5 mg LPS,
whereas all SCID, NKT-deficient, and CD1-deficient
mice survived. However, priming with 50 mg LPS caused
80% mortality of SCID, NKT-, and CD1-deficient mice.
Table II. IFN-g, but Not IL-12, Primes NKT Cell–deficient 
Mice for the Generalized Shwartzman Reaction
Strain Priming Challenge
Deaths/
tested Mortality TNF-a
n % ng/ml
C57BL/6 IL-12 LPS 13/15 86 91 6 11
C57BL/6 NKT2/2 IL-12 LPS 1/15 7* 0.3 6 0.05‡
C57BL/6 IFN-g LPS 12/15 80 65 6 8
C57BL/6 NKT2/2 IFN-g LPS 10/15 67* 54 6 6‡
*P , 0.00001 by the x2 test compared with normal C57BL/6 mice.
‡Statistically significant compared with normal C57BL/6 mice (P ,
0.0001 by Student’s t test).
Figure 3. Induction of the Shwartzman reaction in normal C57BL/6
(j), SCID (s), NKT-deficient (h), and CD1-deficient (d) mice. Mice
were primed by intravenous injection of different doses of phenol-
extracted LPS (A), or phenol-extracted and ion-exchange chromato-
graphy–purified LPS (B). 24 h later, they were challenged by intravenous
injection of 400 mg phenol-extracted LPS.1650 NKT-deficient Mice Are Resistant to Shwartzman Reaction
We interpret these results to indicate that NKT cells
make a major contribution to the Shwartzman reaction
elicited by low doses of LPS, whereas at higher doses of
LPS NK cells play a prominent role. The relative contribu-
tion of NKT and NK cells might be variably dependent on
the amount of IL-12 produced in response to the doses of
LPS administered. It has been recently demonstrated that
both NK and NKT cells constitutively express the IL-12
receptor (7), although the expression on NKT cells was
higher than that on NK cells (7). Therefore, the large
amount of IL-12 produced by injection of high doses of
LPS in NKT-deficient mice might be sufficient to activate
NK cells to overcome the impairment of NKT cells,
which would be preferentially responsive to lower doses of
IL-12 (and, by extension, of LPS). This possibility has been
recently raised to explain controversial results on the role
of NK and NKT cells in IL-12–induced immune responses
in vivo, with particular regard to its antitumor effects (7,
22, 23).
In conclusion, a comprehensive explanation of the
pathogenesis of the Shwartzman reaction emerges,
whereby: LPS-induced IL-12 production by macrophages
promotes IFN-g production by NKT or NK cells (first
priming step), and subsequent challenge with LPS induces
massive production of inflammatory cytokines (including
TNF-a) by IFN-g–sensitized macrophages (second effec-
tor step), which then cause hepatocyte necrosis/apoptosis
and death. The novel important finding here is that NKT
cells as a source of IFN-g after LPS or IL-12 priming play
an essential pathogenic role in the development of general-
ized Shwartzman reactions.
The identification of this role of NKT cells opens new
possibilities for cell-targeted intervention against diseases
that may involve this pathogenesis (e.g., tuberculosis [24]).
One possibility could involve ligands resulting in Fas-medi-
ated apoptosis of NKT cells (25). Finally, our data also in-
dicate that it may be prudent to exercise caution when
considering the use of IL-12 as a vaccine adjuvant (26).
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